Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Scott, Duncan E., Bayly, Andrew R., Abell, Chris, Skidmore, John·2016·Nature Reviews Drug Discovery

Cited by (1,001)

Items 201–300 of 1,001

  1. Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly(propylene sulfide) scaffolds loaded with poorly water-soluble drugs
    Suwei Zhu, Shuoran Li, Helena Escuin-Ordinas, Robert Dimatteo, Weixian Xi, Antoni Ribas, Tatiana Segura · 2018 · Journal of Controlled Release
  2. Modulating Protein–Protein Interactions with Visible‐Light‐Responsive Peptide Backbone Photoswitches
    Lea Albert, Alberto Peñalver, Nemanja Djoković, Laura Werel, Malte Hoffarth, Dušan Ružić, Jing Xu, Lars‐Oliver Essen, Katarina M. Nikolic, Yali Dou et al. · 2019 · ChemBioChem
  3. Microscale Thermophoresis as a Tool to Study Protein Interactions and Their Implication in Human Diseases
    Romain Magnez, Christian Bailly, Xavier Thuru · 2022 · International Journal of Molecular Sciences
  4. Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma
    Fan Huang, Feiyang Cai, Michael S. Dahabieh, Kshemaka Gunawardena, Ali Talebi, Jonas Dehairs, Farah El-Turk, Jae Yeon Park, Mengqi Li, Christophe Gonçalves et al. · 2023 · Journal of Clinical Investigation
  5. Bioactive cell penetrating peptides and proteins in cancer: a bright future ahead
    Toni Jauset, Marie-Ève Beaulieu · 2019 · Current Opinion in Pharmacology
  6. A story of peptides, lipophilicity and chromatography – back and forth in time
    Vanessa Erckes, Christian Steuer · 2022 · RSC Medicinal Chemistry
  7. Scanning Protein Surfaces with DNA‐Encoded Libraries
    Verena B. K. Kunig, Marco Potowski, Mateja Klika Škopić, Andreas Brunschweiger · 2020 · ChemMedChem
  8. Targeting protein-protein interaction interfaces in COVID-19 drug discovery
    Chung‐ke Chang, Shanmeng Lin, Roshan Satange, Shih‐Chao Lin, Sin-Cih Sun, Hung‐Yi Wu, Kylene Kehn‐Hall, Ming‐Hon Hou · 2021 · Computational and Structural Biotechnology Journal
  9. Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development
    Meenakshi Bose, Gabriela Farias Quipildor, Michelle E. Ehrlich, Stephen R. Salton · 2022 · Cells
  10. A general-purpose Nanohybrid fabricated by Polymeric Au(I)-peptide precursor to wake the function of Peptide Therapeutics
    Jin Yan, Fanpu Ji, Siqi Yan, Weiming You, Fang Ma, Fanni Li, Yinong Huang, Wenjia Liu, Wangxiao He · 2020 · Theranostics
  11. Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1–Nrf2 Protein–Protein Interaction
    Fabio Begnini, Stefan Geschwindner, Patrik Johansson, Lisa Wissler, Richard J. Lewis, Emma Danelius, Andreas Luttens, Pierre G. Matricon, Jens Carlsson, Stijn Lenders et al. · 2022 · Journal of Medicinal Chemistry
  12. Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications
    Zohre Eftekhari, Horieh Zohrabi, Akbar Oghalaie, Tahereh Ebrahimi, Fatemeh Sadat Shariati, Mahdi Behdani, Fatemeh Kazemi‐Lomedasht · 2024 · Molecular Therapy — Nucleic Acids
  13. A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases
    Caterina Vicidomini, Francesco Fontanella, Tiziana D’Alessandro, Giovanni Nicola Roviello · 2024 · Biomolecules
  14. Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases
    Qi Li, Shuaishuai Xing, Ying Chen, Qinghong Liao, Qihang Li, Yang Liu, Siyu He, Feng Feng, Yao Chen, Jie Zhang et al. · 2019 · European Journal of Medicinal Chemistry
  15. Modulating Protein–Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples
    Rosario González‐Muñiz, M. Ángeles Bonache, M. Jesús Pérez de Vega · 2021 · Molecules
  16. TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer
    María Paz Saldías, Diego Maureira, Octavio Orellana‐Serradell, Ian Silva, Boris J. Lavanderos, Pablo Cruz, Camila Torres, Mónica Cáceres, Oscar Cerda · 2021 · Frontiers in Oncology
  17. Antibody-Mediated Small Molecule Detection Using Programmable DNA-Switches
    Marianna Rossetti, Rudy Ippodrino, Bruna Marini, Giuseppe Palleschi, Alessandro Porchetta · 2018 · Analytical Chemistry
  18. LuTHy: a double‐readout bioluminescence‐based two‐hybrid technology for quantitative mapping of protein–protein interactions in mammalian cells
    Philipp Trepte, Sabrina Kruse, Simona Kostova, Sheila Hoffmann, Alexander Buntru, Anne Tempelmeier, Christopher Secker, Lisa Diez, Aline Schulz, Konrad Klockmeier et al. · 2018 · Molecular Systems Biology
  19. Targeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions
    Antoine Mousson, Émilie Sick, Philippe Carl, Denis Dujardin, Jan De Mey, Philippe Rondé · 2018 · Cancers
  20. Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase
    Wei-Wei Kung, Sarath Ramachandran, Nikolai Makukhin, Elvira Bruno, Alessio Ciulli · 2019 · Nature Communications
  21. Towards the quantum-enabled technologies for development of drugs or delivery systems
    Parichehr Hassanzadeh · 2020 · Journal of Controlled Release
  22. Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)
    Yuran Qiu, Xinyi Li, Xinheng He, Jun Pu, Jian Zhang, Shaoyong Lu · 2020 · European Journal of Medicinal Chemistry
  23. Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer
    Clare F. Malone, Neekesh V. Dharia, Guillaume Kugener, Alexandra B. Forman, Michael V. Rothberg, Mai Abdusamad, Alfredo E. Gonzalez, Miljan Kuljanin, Amanda L. Robichaud, Amy Saur Conway et al. · 2021 · Cancer Discovery
  24. Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
    Lisha Sun, Yixiao Zhang, Guanglei Chen, Yaoting Ji, Qingtian Ma, Xinbo Qiao, Sijin Wu, Lin Mei Zhou, Jiawen Bu, Xudong Zhu et al. · 2022 · Molecular Cancer
  25. What Makes a Good Protein–Protein Interaction Stabilizer: Analysis and Application of the Dual-Binding Mechanism
    Shuyu Chen, Martin Zacharias · 2023 · ACS Central Science
  26. Fabricating higher-order functional DNA origami structures to reveal biological processes at multiple scales
    Yihao Zhou, Jinyi Dong, Qiangbin Wang · 2023 · NPG Asia Materials
  27. From Concepts to Inhibitors: A Blueprint for Targeting Protein–Protein Interactions
    Seong Ho Hong, Thu Trang Nguyễn, Joseph F. Ongkingco, Alex Nazzaro, Paramjit S. Arora · 2025 · Chemical Reviews
  28. Plasmon-Mediated Surface Engineering of Silver Nanowires for Surface-Enhanced Raman Scattering
    Gang Lü, Haifeng Yuan, Liang Su, Bart Kenens, Yasuhiko Fujita, Maha Chamtouri, Maria Pszona, Eduard Fron, Jacek W. Waluk, Johan Hofkens et al. · 2017 · The Journal of Physical Chemistry Letters
  29. Interaction Energetics and Druggability of the Protein–Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2)
    Mengqi Zhong, A.J. Lynch, Samantha N. Muellers, Stefan Jehle, Lingqi Luo, David R. Hall, Reina Iwase, James P. Carolan, Megan E. Egbert, Amanda Wakefield et al. · 2019 · Biochemistry
  30. Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
    Afsaneh Sadremomtaz, Zayana M. Al-Dahmani, Angel Jonathan Ruiz-Moreno, Alessandra Monti, Chao Wang, Taha Azad, John Cameron Bell, Nunzianna Doti, Marco Antonio Velasco-Velázquez, Debora de Jong et al. · 2021 · Journal of Medicinal Chemistry
  31. High-throughput screen for inhibitors of protein–protein interactions in a reconstituted heat shock protein 70 (Hsp70) complex
    Isabelle R. Taylor, Bryan M. Dunyak, Tomoko Komiyama, Hao Shao, Ran Xu, Victoria A. Assimon, Chakrapani Kalyanaraman, Jennifer N. Rauch, Matthew P. Jacobson, Erik R. P. Zuiderweg et al. · 2018 · Journal of Biological Chemistry
  32. The role of the gap junction perinexus in cardiac conduction: Potential as a novel anti-arrhythmic drug target
    Daniel T. Hoagland, Webster L. Santos, Steven Poelzing, Robert G. Gourdie · 2018 · Progress in Biophysics and Molecular Biology
  33. A tetrameric protein scaffold as a nano-carrier of antitumor peptides for cancer therapy
    Bohan Ma, F. Niu, Xiaoyan Qu, Wangxiao He, Chao Feng, Simeng Wang, Zhenlin Ouyang, Jin Yan, Yurong Wen, Dan Xu et al. · 2019 · Biomaterials
  34. Guest Binding Drives Host Redistribution in Libraries of CoII4L4 Cages
    Marion Kieffer, Rana A. Bilbeisi, John D. Thoburn, Jack Kay Clegg, Jonathan R. Nitschke · 2020 · Angewandte Chemie International Edition
  35. Targeted covalent inhibitors of MDM2 using electrophile-bearing stapled peptides
    Charoenpattarapreeda, Jiraborrirak, Tan, Yaw Sing, Iegre, Jessica, Walsh, Stephen J., Fowler, Elaine, Eapen, Rohan S., Wu, Yuteng, Sore, Hannah F., Verma, Chandra S., Itzhaki, Laura et al. · 2019 · Chemical Communications
  36. A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities
    Jianfeng Lou, Yuhang Lu, Jing Cheng, Feilong Zhou, Ziqin Yan, Daizhou Zhang, Xiangjing Meng, Yujun Zhao · 2022 · European Journal of Medicinal Chemistry
  37. Identification of Covalent Cyclic Peptide Inhibitors Targeting Protein–Protein Interactions Using Phage Display
    Sijie Wang, Franco F. Faucher, Matilde Bertolini, Heeyoung Kim, Bingchen Yu, Li Cao, Katharina Röltgen, Scott Lovell, Varun R. Shanker, Scott Dexter Boyd et al. · 2025 · Journal of the American Chemical Society
  38. Exploiting β‐Amino Acid Enolates in Direct Catalytic Diastereo‐ and Enantioselective C−C Bond‐Forming Reactions
    Jin‐Sheng Yu, Hidetoshi Noda, Masakatsu Shibasaki · 2018 · Chemistry - A European Journal
  39. Macrocyclization of an all- d linear α-helical peptide imparts cellular permeability
    Srinivasaraghavan Kannan, Pietro G. A. Aronica, Simon Ng, Dawn Thean Gek Lian, Yuri Frosi, Sharon Min Qi Chee, Shimin Jiang, Tsz Ying Yuen, Ahmad Sadruddin, Hung Yi Kristal Kaan et al. · 2020 · Chemical Science
  40. Fluorescence Anisotropy-Based Tethering for Discovery of Protein–Protein Interaction Stabilizers
    Eline Sijbesma, Bente A. Somsen, Galen P. Miley, Iris A. Leijten-van de Gevel, Luc Brunsveld, Michelle R. Arkin, Christian Ottmann · 2020 · ACS Chemical Biology
  41. Structural and functional insights into aldosterone synthase interaction with its redox partner protein adrenodoxin
    Simone Brixius‐Anderko, Emily E. Scott · 2021 · Journal of Biological Chemistry
  42. The present and the future of motif-mediated protein–protein interactions
    Moon‐Hyeong Seo, Philip M. Kim · 2018 · Current Opinion in Structural Biology
  43. Allosteric Modulators of Protein–Protein Interactions (PPIs)
    Duan Ni, Na Liu, Chunquan Sheng · 2019 · Advances in experimental medicine and biology
  44. Modulators of protein–protein interactions as antimicrobial agents
    Rashi Kahan, Dennis J. Worm, Guilherme V. Castro, Simon Ng, Anna Barnard · 2021 · RSC Chemical Biology
  45. Oxidation of Innate Immune Checkpoint CD47 on Cancer Cells with Non-Thermal Plasma
    Abraham G. Lin, Jamoliddin Razzokov, Hanne Verswyvel, Angela Privat‐Maldonado, Joey De Backer, Maksudbek Yusupov, Edgar Cardenas De La Hoz, Peter Ponsaerts, Evelien Smits, Annemie Bogaerts · 2021 · Cancers
  46. An Exploration of Chemical Properties Required for Cooperative Stabilization of the 14-3-3 Interaction with NF-κB—Utilizing a Reversible Covalent Tethering Approach
    M. Wolter, Dario Valenti, Peter J. Cossar, Stanimira Hristeva, Laura M. Levy, Thorsten Genski, Torsten Hoffmann, Luc Brunsveld, Dimitrios Tzalis, Christian Ottmann · 2021 · Journal of Medicinal Chemistry
  47. Quantitative FRET (qFRET) Technology for the Determination of Protein–Protein Interaction Affinity in Solution
    Jiayu Liao, Vipul Madahar, Runrui Dang, Ling Jiang · 2021 · Molecules
  48. Blocker-SELEX: a structure-guided strategy for developing inhibitory aptamers disrupting undruggable transcription factor interactions
    Tongqing Li, Xueying Liu, Haifeng Qian, Sheyu Zhang, Yu Hou, Yuchao Zhang, Guoyan Luo, Xun Zhu, Yanxin Tao, Mengyang Fan et al. · 2024 · Nature Communications
  49. Protein–protein interactions in bacteria: a promising and challenging avenue towards the discovery of new antibiotics
    Laura Carro · 2018 · Beilstein Journal of Organic Chemistry
  50. Affinity Selections of DNA‐Encoded Chemical Libraries on Carbonic Anhydrase IX‐Expressing Tumor Cells Reveal a Dependence on Ligand Valence
    Sebastian Oehler, Marco Catalano, Ilario Scapozza, Martina Bigatti, Gabriele Bassi, Nicholas Favalli, Michael R. Mortensen, Florent Samain, Jörg Scheuermann, Dario Neri · 2021 · Chemistry - A European Journal
  51. Genetically encoding latent bioreactive amino acids and the development of covalent protein drugs
    Nanxi Wang, Lei Wang · 2021 · Current Opinion in Chemical Biology
  52. Disruption of protein function by pathogenic mutations: common and uncommon mechanisms
    Mikko Taipale · 2018 · Biochemistry and Cell Biology
  53. Component stabilizing mechanism of membrane-separated hydrolysates on frozen surimi
    Yueying Zhai, Wanqi Peng, Wei Luo, Jinhong Wu, Yongle Liu, Faxiang Wang, Xianghong Li, Jian Yu, Shaoyun Wang · 2023 · Food Chemistry
  54. Mimicking Strategy for Protein–Protein Interaction Inhibitor Discovery by Virtual Screening
    Ke‐Jia Wu, Pui-Man Lei, Hao Liu, Chun Wu, Chung‐Hang Leung, Dik‐Lung Ma · 2019 · Molecules
  55. Covalent Targeting of Ras G12C by Rationally Designed Peptidomimetics
    Daniel Y. Yoo, Andrew D. Hauser, Stephen T. Joy, Dafna Bar‐Sagi, Paramjit S. Arora · 2020 · ACS Chemical Biology
  56. Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury
    Le Zhang, Lijuan Xu, Haihu Chen, Wannian Zhang, Chengguo Xing, Zhuo Qu, Jian‐Qiang Yu, Chunlin Zhuang · 2021 · European Journal of Medicinal Chemistry
  57. Recent progress in nanomedicine-mediated cytosolic delivery
    Hangyu Son, Jeongsu Shin, Joonhyuck Park · 2023 · RSC Advances
  58. Citrullination modulation stabilizes HIF-1α to promote tumour progression
    Rui Chen, Zhiyuan Lin, Shengqi Shen, Chuxu Zhu, Kai Yan, Caixia Suo, Rui Liu, Haoran Wei, Li Gao, Kaixiang Fan et al. · 2024 · Nature Communications
  59. Invasive fungal infections in the immunocompromised host: Mechanistic insights in an era of changing immunotherapeutics
    Christopher P. Eades, Darius P. H. Armstrong-James · 2018 · Medical Mycology
  60. Peptide-assisted Intracellular Delivery of Biomacromolecules
    Shiroh Futaki, Jan Vincent V. Arafiles, H. Hirose · 2020 · Chemistry Letters
  61. Serotonin Alters the Phase Equilibrium of a Ternary Mixture of Phospholipids and Cholesterol
    Oskar Engberg, Anna Maria Bochicchio, Astrid F. Brandner, Ankur Gupta, Simli Dey, Rainer A. Böckmann, Sudipta Maiti, Daniel Huster · 2020 · Frontiers in Physiology
  62. High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics
    Jeffrey R. Simard, Linda Lee, Ellen F. Vieux, Reina Improgo, Trang N. Tieu, Andrew J. Phillips, Stewart L. Fisher, Roy M. Pollock, Eunice Y. Park · 2021 · SLAS DISCOVERY
  63. Amphipathic helical peptides hamper protein-protein interactions of the intrinsically disordered chromatin nuclear protein 1 (NUPR1)
    Patricia Santofimia‐Castaño, Bruno Rizzuti, Olga Abián, Adrián Velázquez‐Campoy, Juan Iovanna, José L. Neira · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
  64. Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing
    E. Sıla Özdemir, Farideh Halakou, Ruth Nussinov, Attila Gürsoy, Özlem Keskin · 2018 · Methods in molecular biology
  65. Checks and Balances in Bacterial Cell Division
    Tanneke den Blaauwen, Joen Luirink · 2019 · mBio
  66. Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells
    Matthias Barone, Matthias Müller, Slim Chiha, Jiang Ren, Dominik Albat, Arne Soicke, Stephan Dohmen, Marco Tobias Klein, Judith Bruns, Maarten van Dinther et al. · 2020 · Proceedings of the National Academy of Sciences
  67. Research progress of biosensors for detection of SARS-CoV-2 variants based on ACE2
    Hongshuai Wei, Congcong Zhang, Xin Du, Zhenguo Zhang · 2022 · Talanta
  68. De Novo Modular Development of a Foldameric Protein–Protein Interaction Inhibitor for Separate Hot Spots: A Dynamic Covalent Assembly Approach
    Éva Bartus, Zsófia Hegedüs, Edit Wéber, Brigitta Csipak, Gerda Szakonyi, Tamás A. Martinek · 2017 · ChemistryOpen
  69. Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation ofERGsuper-enhancer in erythroleukemia cells
    Ryusuke Yamamoto, Masahiro Kawahara, Shinji Ito, Junko Satoh, Goichi Tatsumi, Masakatsu Hishizawa, Takayoshi Suzuki, Akira Andoh · 2018 · Oncotarget
  70. Docking-based identification of small-molecule binding sites at protein-protein interfaces
    Mireia Rosell, Juan Fernández‐Recio · 2020 · Computational and Structural Biotechnology Journal
  71. Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptake
    Aline D. de Araujo, Junxian Lim, Kai‐Chen Wu, Huy N. Hoang, Huy T. Nguyen, David P. Fairlie · 2022 · RSC Chemical Biology
  72. A 3D structural SARS-CoV-2–human interactome to explore genetic and drug perturbations
    Wierbowski, Shayne D., Liang, Siqi, Liu, Yuan, Chen, You, Gupta, Shagun, Andre, Nicole M., Lipkin, Steven M., Whittaker, Gary R., Yu, Haiyuan · 2021 · Nature Methods
  73. Selective fluorescent labeling of cellular proteins and its biological applications
    Joo Hee Choi, Sooin Kim, On‐Yu Kang, Seong Yun Choi, Ji Young Hyun, Hyun Soo Lee, Injae Shin · 2024 · Chemical Society Reviews
  74. Targeting the cryptic sites: NMR-based strategy to improve protein druggability by controlling the conformational equilibrium
    Yumiko Mizukoshi, Koh Takeuchi, Yuji Tokunaga, Hitomi Matsuo, Misaki Imai, Miwa Fujisaki, Hajime Kamoshida, Takeshi Takizawa, Hiroyuki Hanzawa, Ichio Shimada · 2020 · Science Advances
  75. Specific inhibition of the Survivin–CRM1 interaction by peptide-modified molecular tweezers
    Annika Meiners, Sandra Bäcker, Inesa Hadrović, Christian Heid, Christine Beuck, Yasser B. Ruiz‐Blanco, Joel Mieres‐Pérez, Marius Pörschke, Jean‐Noël Grad, Cecilia Vallet et al. · 2021 · Nature Communications
  76. Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far
    Ahmed Elwakeel · 2022 · Frontiers in Cell and Developmental Biology
  77. Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del
    Frederik Ernst Deiman, Nils Bömer, Peter van der Meer, Niels Grote Beverborg · 2022 · Current Heart Failure Reports
  78. Drug discovery by targeting the protein–protein interactions involved in autophagy
    Honggang Xiang, Mi Zhou, Yan Li, Lu Zhou, Renxiao Wang · 2023 · Acta Pharmaceutica Sinica B
  79. PocketAnchor: Learning structure-based pocket representations for protein-ligand interaction prediction
    Shuya Li, Tingzhong Tian, Ziting Zhang, Ziheng Zou, Dan Yang Zhao, Jianyang Zeng · 2023 · Cell Systems
  80. Small-Molecule Inhibitors of the CD40–CD40L Costimulatory Protein–Protein Interaction
    Jinshui Chen, Yun Gyu Song, Damir Bojadzic, Alejandro Tamayo, Ana Marie Landin, Bonnie B. Blomberg, Péter Buchwald · 2017 · Journal of Medicinal Chemistry
  81. Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target
    G. M. Watson, Ketav Kulkarni, Jianrong Sang, Xiuquan Ma, Menachem J. Gunzburg, Patrick Perlmutter, Matthew C. J. Wilce, Matthew C. J. Wilce · 2017 · Journal of Medicinal Chemistry
  82. Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease
    Ganeshpurkar, Ankit, Swetha, Rayala, Kumar, Devendra, Gangaram, Gore P., Singh, Ravi, Gutti, Gopichand, Jana, Srabanti, Kumar, Dileep, Kumar, Ashok, Singh, Sushil K. · 2019 · Current Topics in Medicinal Chemistry
  83. Total Synthesis of Strempeliopidine and Non-Natural Stereoisomers through a Convergent Petasis Borono–Mannich Reaction
    Alexander W. Rand, Kevin J. Gonzalez, Christopher E. Reimann, Scott C. Virgil, Brian M. Stoltz · 2023 · Journal of the American Chemical Society
  84. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5–MEP50 Complex
    Adrian Krzyzanowski, Raphael Gasper, Hélène Adihou, Peter ‘t Hart, Herbert Waldmann · 2021 · ChemBioChem
  85. Identification and optimization of molecular glue compounds that inhibit a noncovalent E2 enzyme–ubiquitin complex
    Daniel J. St‐Cyr, Derek F. J. Ceccarelli, Stephen M. Orlicky, Almer M. van der Sloot, Xiaojing Tang, Susan Kelso, Susan Moore, Clint A. James, Ganna Posternak, Jasmin Coulombe‐Huntington et al. · 2021 · Science Advances
  86. Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapies
    Dezső Módos, Krishna C. Bulusu, Dávid Fazekas, János Kubisch, Johanne Brooks, István Marczell, Péter Márton Szabó, Tibor Vellai, Péter Csermely, Katalin Lenti et al. · 2017 · npj Systems Biology and Applications
  87. Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies
    Christina Schiza, Dimitrios Korbakis, Efstratia Panteleli, Keith Allen Jarvi, Andrei P. Drabovich, Eleftherios P. Diamandis · 2018 · Molecular & Cellular Proteomics
  88. Screening-based approaches to identify small molecules that inhibit protein–protein interactions
    Choi, Sehee, Choi, Kang-Yell · 2017 · Expert Opinion on Drug Discovery
  89. Concise Synthesis of Tetrazole Macrocycle
    Eman M. M. Abdelraheem, Michel P. de Haan, Pravin Patil, Katarzyna Kurpiewska, Justyna Kalinowska‐Tłuścik, Shabnam Shaabani, Alexander S. S. Dömling · 2017 · Organic Letters
  90. Prediction of Hot Regions in PPIs Based on Improved Local Community Structure Detecting
    Xiaoli Lin, Xiaolong Zhang · 2018 · IEEE Transactions on Computational Biology and Bioinformatics
  91. Reversible Interacting-Particle Reaction Dynamics
    Christoph Fröhner, Frank Noé · 2018 · The Journal of Physical Chemistry B
  92. Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives
    Sara La Manna, Ilaria De Benedictis, Daniela Marasco · 2022 · Frontiers in Molecular Biosciences
  93. High-Throughput Screening of Stapled Helical Peptides in Drug Discovery
    Yiwei Zhang, Jiabei Guo, Jiongjia Cheng, Zhenghua Zhang, Fenghua Kang, Xiaoxing Wu, Qian Chu · 2022 · Journal of Medicinal Chemistry
  94. Transformer Performance for Chemical Reactions: Analysis of Different Predictive and Evaluation Scenarios
    Fernando Jaume-Santero, Alban Bornet, Alain Valery, Nona Naderi, David Vicente Alvarez, Dimitrios Proios, Anthony Yazdani, Colin Bournez, Thomas C. Fessard, Douglas Teodoro · 2023 · Journal of Chemical Information and Modeling
  95. Sensitive CRISPR-Cas12a-Assisted Immunoassay for Small Molecule Detection in Homogeneous Solution
    Fengxi Zhu, Qiang Zhao · 2023 · Analytical Chemistry
  96. A gated graph transformer for protein complex structure quality assessment and its performance in CASP15
    Xiao Chen, Alex Morehead, Jian Liu, Jianlin Cheng · 2023 · Bioinformatics
  97. Rational design and structure–activity relationship studies of quercetin–amino acid hybrids targeting the anti-apoptotic protein Bcl-xL
    Tahsin F. Kellici, Μaria V. Chatziathanasiadou, Min‐Sung Lee, Nisar Sayyad, Elena G. Geromichalou, Eirinaios I. Vrettos, Antonis D. Tsiailanis, Seung‐Wook Chi, George D. Geromichalos, Thomas Mavromoustakos et al. · 2017 · Organic & Biomolecular Chemistry
  98. Potent Inhibitors of Mycobacterium tuberculosis Growth Identified by Using in-Cell NMR-based Screening
    Christopher M. DeMott, Roxie C. Girardin, Jacqueline Cobbert, Sergey Reverdatto, David S. Burz, Kathleen A. McDonough, Alexander G. Shekhtman · 2018 · ACS Chemical Biology
  99. CORUM in 2024: protein complexes as drug targets
    Ralph Steinkamp, George Tsitsiridis, Barbara Brauner, Corinna Montrone, Gisela Fobo, Goar Frishman, Sorin I. Avram, Tudor Ionel Oprea, Andreas Ruepp · 2024 · Nucleic Acids Research
  100. Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy
    Ioannis D Kyrochristos, Dimosthenis E. Ziogas, Dimitrios H Roukos · 2019 · Drug Discovery Today